Frias JP, Hsia S, Erichsen L, et al
Oral & even IM treatment with Cyano-B12 were ineffective, but IM treatment with your Methyl-B12 so far appears to be very effective
GLP-1 programs help by slowing digestion and reducing appetite, making it easier to maintain consistent and balanced eating habits
Pfizer reported positive Phase 2b results for its investigational ultra long acting GLP 1 receptor agonist, PF 3944, demonstrating continued weight loss after transitioning from weekly to monthly dosing, with no plateau observed at 28 weeks
If the peptide space follows a similar trajectory to GLP-1s, I believe the next major wave will come from compounds like SS-31 and other research targeting cellular energetics and mitochondrial dysfunctionthe true root of aging and chronic disease
Paused during the COVID-19 pandemic, redetermination now takes place annually